Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Search Results: PARP inhibitors

Showing 12 out of 107 results
Pink ribbon chocolates

Triple negative breast cancer has poorer survival and is less well understood than other types, but research is making a difference. Triple negative breast cancer has poorer survival and is less well understood than other types, but research is making a difference.

by Kat Arney | Analysis | 30 June 2014

30 June 2014

This week's big cancer news stories included research into cancer's genetic fingerprint, skin cancer drug approval, a childhood brain tumour trial and more. This week's big cancer news stories included research into cancer's genetic fingerprint, skin cancer drug approval, a childhood brain tumour trial and more.

by Oliver Childs | Analysis | 16 August 2013

16 August 2013

  • Health & Medicine

The story of temozolomide

From its early development in the 1970's to its use as an important treatment for adult brain tumours, we explore the history of the cancer drug temozolomide. From its early development in the 1970's to its use as an important treatment for adult brain tumours, we explore the history of the cancer drug temozolomide.

by Kat Arney | Analysis | 18 July 2013

18 July 2013

This entry is part 13 of 30 in the series Our milestones
Cancer Research UK logo
  • Science & Technology
  • Health & Medicine

Angelina Jolie, inherited breast cancer and the BRCA1 gene

Celebrity cancer stories often hit the headlines - we answer some key questions following recent reports of genetic risks for breast cancer. Celebrity cancer stories often hit the headlines - we answer some key questions following recent reports of genetic risks for breast cancer.

by Henry Scowcroft | Analysis | 14 May 2013

14 May 2013

  • Science & Technology

Tracking down the BRCA2 gene

Our scientists discovered the second breast cancer gene, BRCA2 - we discuss how they made the finding and what this means for cancer patients. Our scientists discovered the second breast cancer gene, BRCA2 - we discuss how they made the finding and what this means for cancer patients.

by Kat Arney | Analysis | 29 February 2012

29 February 2012

This entry is part 10 of 30 in the series Our milestones
Cancer Research UK logo

Cancer Research UK's Drug Development Office has re-launched a trial of a promising drug to treat inherited breast and ovarian cancer - but this time taken as a tablet by outpatients. Cancer Research UK's Drug Development Office has re-launched a trial of a promising drug to treat inherited breast and ovarian cancer - but this time taken as a tablet by outpatients.

by Cancer Research UK | News | 11 January 2012

11 January 2012